4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis
(By Brian Mann for NPR) Four of the largest U.S. corporations have agreed to pay roughly $26 billion to settle
Read More
Part D/Prescription Drugs
Plan to Fix Postal Service Shifts New Retirees to Medicare — Along With Billions in Costs
(By Michael McAuliff for Kaiser Health News) A congressional effort to fix the nation’s deteriorating mail service may come at
Read MoreHow CMS looks at ‘fully vaccinated’ under mandate
(By Kelly Gooch for Becker’s Hospital Review) As CMS’ COVID-19 vaccination mandate is in effect nationwide, the agency is allowing
Read MoreCopay coupons are exacerbating drug price inflation, economists say
(By Katie Adams for Becker’s Hospital Review) Drug copay coupons offer patients savings on prescriptions, but they significantly increase amounts
Read MoreInside the Tactical Tug of War Over the Controversial Alzheimer’s Drug
(By Arthur Allen for Kaiser Health News) The drug industry, patient advocates, and congressional Republicans have all attacked federal officials’
Read MoreFDA wary of drugs developed in China
(By Erica Carbajal for Becker’s Hospital Review) The FDA is concerned about the quality of studies evaluating cancer drugs and
Read MoreHow do prescription drug costs in the United States compare to other countries?
(By Nisha Kurani, Dustin Cotliar, and Cynthia Cox for Kaiser Family Foundation published February 8, 2022) More than three in
Read MoreWhy remdesivir, a highly effective COVID treatment, is a last resort for providers
(By Pien Huang for NPR) In late December, as the omicron variant surged, the roster of early COVID-19 treatments was
Read MoreCMS pitches Medicare Advantage rate, Part D payment policy changes: 9 details
(By Nick Moran for Becker’s Hospital Review) CMS is seeking input on an Advanced Notice that includes proposed changes to
Read MoreFeds’ contract with Pfizer for Paxlovid has some surprises
(By Sydney Lupkin for NPR) The United States is spending about $530 for each 5-day course of Pfizer’s COVID-19 pill,
Read More